Eubulus
Jiaxing
About Eubulus
Eubulus is an early-stage company focusing on building a platform technology for therapeutic enhancement. The company specializes in Proteolysis- targeting chimeras (PROTACSs).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $10.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2021)
Industries & Categories
Biotechnology, Medical, Therapeutics
Canonical: https://fsome.com/organization/eubulus-134453 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.